BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk 
Welcome,         Profile    Billing    Logout  
 10 Diseases   7 Trials   7 Trials   222 News 
1 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk
2017-000092-84: Comparison of SAR341402 Mix 70/30 to NovoMix 30 in Adult Patients with Diabetes Mellitus Using Pre-Mix Insulin Analogs.

Not yet recruiting
3
600
Europe
SAR341402, Suspension for injection, Suspension for injection in pre-filled pen, NovoMix 30
Sanofi-aventis recherche & développement, Sanofi-aventis recherche & développement
Type 1 Diabetes MellitusType 2 Diabetes Mellitus, Type 1 Diabetes MellitusType 2 Diabetes Mellitus, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 

Download Options